RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1479
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1463000; Gene model (P.falciparum): PF3D7_1250100; Gene product: osmiophilic body protein G377 (PbG377; G377)
Name tag: mCherry
Phenotype Gametocyte/Gamete;
Last modified: 6 July 2016, 17:34
  *RMgm-1479
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 27371728
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherKehrer J; Frischknecht F, Mair GR
Name Group/DepartmentUniversity of Heidelberg Medical School
Name InstituteUniversity of Heidelberg Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-1479
Principal nameG377::mCherry
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteG377::mCherry expression in female gametocytes. G377::mCherry is trafficked to the periphery of the female gametocytes during gametogenesis consistent with a secretion event for this protein (see also RMgm-263). G377::mCherry was detected in the culture medium only after induction of gamete formation (gametogenesis).
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal mCherry-tagged version of PbG377.

Protein (function)
PbG377 and its P. falciparum ortholog (PfG377) are associated with osmiophilic bodies (OB) and play a role in the emergence of female gametocytes from the host erythrocyte after induction of gamete formation (gametogenesis). See also mutant RMgm-263 that lacks expression of pbG377.

Phenotype
G377::mCherry expression in female gametocytes. G377::mCherry is trafficked to the periphery of the female gametocytes during gametogenesis consistent with a secretion event for this protein (see also RMgm-263). G377::mCherry was detected in the culture medium only after induction of gamete formation (gametogenesis).

Additional information
This mutant is used in a study aiming at identifying 'gametocyte regressome', i.e. proteins that are released when Plasmodium gametes escape from their host reythrocyte. For the release of mature extracellular gametes two membrane barriers - the parasite parasitophorous vacuole membrane and the host red blood cell membrane - need to be dissolved. Membrane lysis occurs after the release of proteins from specialized secretory vesicles including osmiophilic bodies.
The identified Plasmodium gametocyte egressome includes the proteins released by the parasite during the lysis of the parasitophorous vacuole membrane and red blood cell membrane. BioID of the osmiophilic body protein MDV1/PEG3 revealed a proteome of these gametocyte-specific secretory vesicles. Fluorescent protein tagging and gene deletion approaches were employed to validate and identify a set of novel factors essential for this lysis and egress process.

Other mutants
See this link for other mutants generated in this study.
See also mutant RMgm-263 that lacks expression of pbG377.


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1463000
Gene Model P. falciparum ortholog PF3D7_1250100
Gene productosmiophilic body protein G377
Gene product: Alternative namePbG377; G377
Details of the genetic modification
Name of the tagmCherry
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe 3’ end 1470 bps of the G377 (PBANKA_146300) open reading frame (ORF) were PCR-amplified with primers g3092 and g3093 (primer sequence are available on request), digested with PacI and BamHI and ligated in frame with mCherry into a plasmid containing the human DHFR selection marker. Prior to transfection plasmid pLIS0244 was linearised with BstZ17I.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6